Asian Journal of Research in Pharmaceutical Science
  • Year: 2021
  • Volume: 11
  • Issue: 3

A Desk Top Allusion to The Rare Orphan Diseases and Orphan Drugs: Possessions to Discern by Every Healthcare Professional

  • Author:
  • Hindustan Abdul Ahad1, Chinthaginjala Haranath1, Bhupalam Pradeep Kumar2, Debaraj Roy2, Bhavani Haribabu Sai Dharani2, Momin Umaira Ayisha2
  • Total Page Count: 6
  • Published Online: Oct 11, 2021
  • Page Number: 247 to 252

1Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Ananthapuramu - 515721Andhra Pradesh, India

2Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Ananthapuramu - 515721Andhra Pradesh, India

*Corresponding Author E-mail: abdulhindustan@gmail.com

Abstract

This article gives a brief knowledge about orphan diseases and drugs. An orphan disease is a rare illness lack market and resource data for the treatment and the drugs used for their treatment are called orphan drugs. The pharmaceutical firms show less interest in the development of drugs to treat them, and lack profit without government assistance. The authors reviewed published scientific literature and grouped a broad list of Orphan diseases and orphan drugs. The article summarizes the entire list of orphan diseases and drugs with their description.

Keywords

Rare disease, Orphan drug, Government policy, Firms